RU2324688C2 - Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение - Google Patents

Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение Download PDF

Info

Publication number
RU2324688C2
RU2324688C2 RU2003134946/04A RU2003134946A RU2324688C2 RU 2324688 C2 RU2324688 C2 RU 2324688C2 RU 2003134946/04 A RU2003134946/04 A RU 2003134946/04A RU 2003134946 A RU2003134946 A RU 2003134946A RU 2324688 C2 RU2324688 C2 RU 2324688C2
Authority
RU
Russia
Prior art keywords
derivatives
benzisoselenazolonyl
inflammatory
antitumor
pharmaceutically acceptable
Prior art date
Application number
RU2003134946/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003134946A (ru
Inventor
Хуйхуй ЦЕНЬ (CN)
Хуйхуй ЦЕНЬ
Original Assignee
Пекинь Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пекинь Юниверсити filed Critical Пекинь Юниверсити
Publication of RU2003134946A publication Critical patent/RU2003134946A/ru
Application granted granted Critical
Publication of RU2324688C2 publication Critical patent/RU2324688C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2003134946/04A 2001-06-08 2002-06-10 Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение RU2324688C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011186666A CN1166651C (zh) 2001-06-08 2001-06-08 具有抗炎和抗肿瘤作用r-双或糖苯丙异硒唑取代化合物
CN01118666.6 2001-08-06

Publications (2)

Publication Number Publication Date
RU2003134946A RU2003134946A (ru) 2005-06-10
RU2324688C2 true RU2324688C2 (ru) 2008-05-20

Family

ID=4663351

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003134946/04A RU2324688C2 (ru) 2001-06-08 2002-06-10 Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение

Country Status (10)

Country Link
US (2) US7495019B2 (enExample)
EP (1) EP1422225B1 (enExample)
JP (1) JP4500672B2 (enExample)
CN (1) CN1166651C (enExample)
AT (1) ATE540030T1 (enExample)
AU (1) AU2002346271A1 (enExample)
CA (1) CA2450087C (enExample)
ES (1) ES2378983T3 (enExample)
RU (1) RU2324688C2 (enExample)
WO (1) WO2003095436A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4014C2 (ro) * 2009-04-23 2010-09-30 Татьяна ГУЦУЛ Complecşi polioxometalaţi cu activitate antitumorală
RU2810162C2 (ru) * 2019-06-24 2023-12-22 Шанхай Юаньси Медисин Корп. Кристаллическая форма 1,4-бис[1,2-бензизоселеназол-3(2h)-он]-бутана, способ ее получения и применения
US11952356B2 (en) 2019-06-24 2024-04-09 Shanghai Yuanxi Medicine Corp. Crystalline form of 1,4-bis[1,2-benzisoselenazol-3(2H)-one]-butane, method for preparing same and use thereof

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820829B2 (en) * 2001-06-08 2010-10-26 Peking University Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
CN100554255C (zh) * 2004-05-31 2009-10-28 北京大学 苯并异硒唑酮衍生物及其制备方法与应用
CN1990475B (zh) * 2005-12-29 2011-09-07 曾慧慧 取代苯并异硒唑酮类化合物及其用途
US20090005422A1 (en) * 2006-05-22 2009-01-01 Thioredoxin Systems Ab Bacterial thioredoxin reductase inhibitors and methods for use thereof
CN101016319B (zh) * 2007-02-13 2010-08-04 中国海洋大学 苯并异硒唑酮氨基糖衍生物及其制备方法和应用
CN101781283B (zh) * 2009-01-16 2014-04-23 凯熙医药（武汉）股份有限公司 硫氧还蛋白还原酶抑制剂化合物及其制备方法和其应用
CN101921303A (zh) * 2009-06-09 2010-12-22 曾慧慧 苯并异硒唑酮二氟胞苷类化合物及其制备方法和其用途
CN102453050B (zh) * 2010-11-03 2015-01-07 成都云克药业有限责任公司 一种二膦酸化合物及其制备方法
CA2871535A1 (en) * 2012-01-13 2013-07-18 Celgene Corporation Biomarkers for the treatment of hepatocellular carcinoma
CN103483291B (zh) * 2012-06-14 2015-08-12 沈阳药科大学 4,5-二芳基-1,3-硒唑类化合物及其制备方法和用途
CN104177312B (zh) * 2013-05-27 2018-02-13 黄英武 一种含硒化合物及其医药用途
CN105277699B (zh) * 2014-07-21 2017-05-03 武汉尚宜康健科技有限公司 测试试剂在制备评价临床肿瘤患者临床治疗监测的药品中的应用
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110856717A (zh) * 2018-08-06 2020-03-03 上海元熙医药科技有限公司 一种肿瘤免疫调节剂及其用途
WO2023277584A1 (ko) * 2021-06-29 2023-01-05 (주)라이프신약 셀레늄 화합물을 유효성분으로 포함하는 노화세포 제거용 조성물
KR20230002109A (ko) * 2021-06-29 2023-01-05 (주)라이프신약 셀레늄 화합물을 유효성분으로 포함하는 노화세포 제거용 조성물
CN116891443B (zh) * 2023-09-08 2023-12-01 潍坊医学院 一种异吲哚-1-酮衍生物及其制备方法、应用
WO2025169231A1 (en) * 2024-02-09 2025-08-14 Indian Institute Of Science Organoselenium compounds, preparation and implementations thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
US5683863A (en) * 1994-12-22 1997-11-04 Agfa-Gevaert-Ag Photographic silver halide material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3226284A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0198277B1 (de) * 1985-04-12 1989-05-03 A. Nattermann & Cie. GmbH Diselenobis-benzoesäureamide primärer und sekundärer Amine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0199986B1 (de) * 1985-04-27 1990-04-25 A. Nattermann & Cie. GmbH Neue Benzisoselenazolonyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DE3827093A1 (de) * 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
CN1110489C (zh) * 1998-11-11 2003-06-04 中国医学科学院药物研究所 苯并异硒唑酮磺酰胺衍生物及其制法和其在制备药物中的应用
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
US5683863A (en) * 1994-12-22 1997-11-04 Agfa-Gevaert-Ag Photographic silver halide material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OSAJDAM et al // Polish Journal of Chem. (2001), 75(6), 823-830. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4014C2 (ro) * 2009-04-23 2010-09-30 Татьяна ГУЦУЛ Complecşi polioxometalaţi cu activitate antitumorală
RU2810162C2 (ru) * 2019-06-24 2023-12-22 Шанхай Юаньси Медисин Корп. Кристаллическая форма 1,4-бис[1,2-бензизоселеназол-3(2h)-он]-бутана, способ ее получения и применения
US11952356B2 (en) 2019-06-24 2024-04-09 Shanghai Yuanxi Medicine Corp. Crystalline form of 1,4-bis[1,2-benzisoselenazol-3(2H)-one]-butane, method for preparing same and use thereof

Also Published As

Publication number Publication date
AU2002346271A1 (en) 2003-11-11
CA2450087A1 (en) 2003-11-20
US20090117204A1 (en) 2009-05-07
RU2003134946A (ru) 2005-06-10
ES2378983T3 (es) 2012-04-19
ATE540030T1 (de) 2012-01-15
US8609702B2 (en) 2013-12-17
WO2003095436A1 (en) 2003-11-20
JP2005519991A (ja) 2005-07-07
US7495019B2 (en) 2009-02-24
JP4500672B2 (ja) 2010-07-14
CN1390837A (zh) 2003-01-15
EP1422225B1 (en) 2012-01-04
CA2450087C (en) 2012-08-07
CN1166651C (zh) 2004-09-15
EP1422225A1 (en) 2004-05-26
US20050014801A1 (en) 2005-01-20
EP1422225A4 (en) 2004-10-20

Similar Documents

Publication Publication Date Title
RU2324688C2 (ru) Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение
KR100484504B1 (ko) 쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
JP3697210B2 (ja) 二重ジカルボン酸ジアミノプラチン錯体の抗腫瘍誘導体、その調製方法、それを含む薬剤組成物及びその誘導体の適用方法
PT679656E (pt) Melhoramentos em complexos de platina
Ismail et al. Novel synthesis of pyrrolo [2, 3-d] pyrimidines bearing sulfonamide moieties as potential antitumor and radioprotective agents
KR840001965B1 (ko) 안트라센-9,10-비스-카르보닐-히드라존 유도체 제조방법
MX2011001800A (es) Compuestos de arsenico organico y metodos para el tratamiento de cancer.
WO2016119643A1 (zh) 一种含吲哚乙酸核心结构的化合物及其应用
AU619881B2 (en) Platinum (IV)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action, which contains at least one platinum compound, and shaped preparation with an anti-tumour action
US7820829B2 (en) Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
JPH06506226A (ja) 抗ガン剤としてのアミドおよびチオアミドリンカー含有のビス−ナフタルイミド類
CN109467560B (zh) 一种硒氰化合物及其用途
US5621003A (en) Maillard reaction inhibitor
JP2000302762A (ja) 放射線および化学療法における感受性増強剤であるグリシジアゾール金属塩、並びにそれらの製造方法および使用
US20050209321A1 (en) Platinum carboxylate anticancer compounds
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
CN110938033A (zh) 硒氰化合物及其用途
TW202412813A (zh) 含硒元素的查爾酮化合物及其製備方法、包含其的醫藥組合物、以及用於製備預防或治療大腸癌之醫藥組合物的用途
US6921824B1 (en) Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
US4481201A (en) Pharmaceutical composition containing N,N3 -di-(β-bromopropionyl)-N1,N2 -dispirotripiperazinium dichloride
CN110256482A (zh) 一种杂多钒酸盐化合物及其制备方法
JPH01156990A (ja) 新規白金錯体及びその用途
GB2054582A (en) Water soluble derivatives of 6,6-methylene - bis - (2,2,4-trimethyl - 1,2-dihydroquinoline) and process for the preparation thereof
ES2372242B1 (es) Compuesto di{3,5-diacetil-1,2,4-triazol bis(4-ciclohexil tiosemicarbazonato)platino (ii)}, procedimiento de síntesis y su aplicación como fármaco antitumoral.
US20070129431A1 (en) Multinuclear platinum compounds

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20050722

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20050819

FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20060901

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20070307

MM4A The patent is invalid due to non-payment of fees

Effective date: 20200611

NF4A Reinstatement of patent

Effective date: 20211125